Salsalate

Salsalate

SCHEMBL2025628

O=C(Oc1ccccc1C(=O)O)c1ccccc1O.O=C(Oc1ccccc1C(=O)O)c1ccccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 1.00
KDM4E B2RXH2 8/20 1.00
HPGD P15428 7/20 1.00
ALDH1A1 P00352 4/20 1.00
LMNA P02545 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2C9 P11712 1/20 0.67
ALOX15 P16050 2/20 0.65
HMGB1 P09429 2/20 0.61
NAPRT Q6XQN6 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
CA12 O43570 1/20 0.61
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
CA4 P22748 1/20 0.61
CA6 P23280 1/20 0.61
CA7 P43166 1/20 0.61
CA9 Q16790 1/20 0.61
CA14 Q9ULX7 1/20 0.61
ESR1 P03372 6/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salsalate SCHEMBL15562 1.00 HSD17B10 (1.00) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL29362887 1.00 HSD17B10 (1.00) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL9704557 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL12477400 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL1802439 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL25177171 0.98 KDM4E (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
SCHEMBL3264360 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL25260636 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
Salsalate SCHEMBL9624915 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA
SCHEMBL13826872 0.98 HSD17B10 (0.96) HSD17B10KDM4EHPGDALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10004749-B2 Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof HSU JOHN (US) 2018-06-26 US disclosed
US-20170020885-A1 Composition Comprising a Therapeutic Agent and a Respiratory Stimulant and Methods for the Use Thereof HSU JOHN (US) 2017-01-26 US disclosed
US-20110158983-A1 COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES VICUS THERAPEUTICS, LLC 2011-06-30 US disclosed
EP-2054052-A1 DRUG COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USING THEM Vicus Therapeutics SPE 1, LLC (US) 2009-05-06 EP disclosed
WO-2008014471-A1 DRUG COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USING THEM VICUS THERAPEUTICS SPE 1, LLC (US) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170020885-A1 Composition Comprising a Therapeutic Agent and a Respiratory Stimulant and Methods for the Use Thereof OPRM1, OPRL1, OPRK1 HSD17B10 2692/4885KDM4E 2854/4885HPGD 1841/4885
US-10004749-B2 Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof OPRM1, OPRL1, OPRK1 HSD17B10 2692/4885KDM4E 2854/4885HPGD 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.